Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Endogenous and recombinant type I interferons and disease activity in multiple sclerosis.
Consensus statements from a panel of u.s. Managed care pharmacists and physicians for management of multiple sclerosis agents.
PLA2G6 mutations and other rare causes of Neurodegeneration with Brain Iron Accumulation.
[Neuromyelitis optica in the elderly: An unusual demyelinating disease.]
Management of Spasticity in Progressive Multiple Sclerosis: Efficacy of Repeated Intrathecal Triamcinolone Acetonide Administration.
Aging, widowhood, multiple sclerosis, and a dog.
Association of a deficit of arousal with fatigue in multiple sclerosis: Effect of modafinil.
Sexual Behavior, Body Image, and Partnership in Chronic Illness: A Comparison of Huntington's Disease and Multiple Sclerosis.
Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid β-induced memory impairment.
Electroacupuncture Promotes the Differentiation of Transplanted Bone Marrow Mesenchymal Stem Cells Pre-Induced with Neurotrophin-3 and Retinoic Acid into Oligodendrocyte-Like Cells in Demyelinated Spinal Cord of Rats.
Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre.
Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.
IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation.
Association between pathological and MRI findings in multiple sclerosis.
NMO spectrum presenting as partial myelitis.
Acute hypercalcemia following excessive calcium supplementation in a dehydrated patient with progressive multiple sclerosis: vitamin d supplementation is a red herring-reply.
Daughters of mothers with multiple sclerosis: their experiences of play.
Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison.
Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis.
Substance Name: Riluzole
IL-1β induces hypomyelination in the periventricular white matter through inhibition of oligodendrocyte progenitor cell maturation via FYN/MEK/ERK signaling pathway in septic neonatal rats.
Multiple sclerosis reactivation postfingolimod cessation: Is it IRIS?
Vitamin B(12) Deficiency and Multiple Sclerosis; Is there Any Association?
Consensus statements from a panel of u.s. Managed care pharmacists and physicians for management of multiple sclerosis agents.
Do not treat from CIS onset: evaluate disease course and prognosis first - No (treat!).

Pages